Search
WAVE Life Sciences Ltd
WVEAdd to Watchlist
3.960USD
+0.010+0.25%
Close 09-24 16:00（ET）
761.90MMarket Cap
LossP/E TTM
WAVE Life Sciences Ltd (WVE) Stock Price Target & Forecast
Analyst Rating
Based on 17 analysts giving stock ratings to WAVE Life Sciences Ltd in the past month.
Buy
6 Strong Buy
11 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
19.471USD+392.93%
WVE Analyst Recommendation Trends
In the current month, WVE has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. WVE average Analyst price target in the last month is 19.471.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
6
6
5
5
5
5
5
5
11
11
11
11
11
11
11
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
17
16
16
16
16
16
16
WVE Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, WVE EPS is projected to reach -0.330 in FY2026Q3, following reported EPS of -0.340 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.27
-0.33
-0.31
-0.33
-0.34
Actual
-0.29
-0.13
-0.34
--
--
Surprise
-9.22%
+60.25%
-10.02%
--
--
FAQs
What is WAVE Life Sciences Ltd's expected revenue for the next quarter?
WAVE Life Sciences Ltd's expected revenue is 4.71M.
What is WAVE Life Sciences Ltd's price target?
Analysts forecast that WAVE Life Sciences Ltd's price target is USD 19.47, with the highest forecast at USD 42.00 and the lowest forecast at USD 12.00.
How have WAVE Life Sciences LtdWVE's recent earnings per share performed?
The market expectation was USD -0.34, while WAVE Life Sciences LtdWVE's earnings per share (EPS) for the previous quarter was USD -0.13. EPS for the next quarter is expected at USD -0.33.
What is the analyst rating for WAVE Life Sciences Ltd?
Based on the ratings of WAVE Life Sciences Ltd's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.